Interleukin-6–dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer
Top Cited Papers
- 15 August 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (4) , 1330-1333
- https://doi.org/10.1182/blood-2007-03-081133
Abstract
Signal transducer and activator of transcription 3 (Stat3) is implicated in the pathogenesis of many malignancies and essential for IL-6-dependent survival and growth of multiple myeloma cells. Here, we demonstrate that the gene encoding oncogenic microRNA-21 (miR-21) is controlled by an upstream enhancer containing 2 Stat3 binding sites strictly conserved since the first observed evolutionary appearance of miR-21 and Stat3. MiR-21 induction by IL-6 was strictly Stat3 dependent. Ectopically raising miR-21 expression in myeloma cells in the absence of IL-6 significantly reduced their apoptosis levels. These data provide strong evidence that miR-21 induction contributes to the oncogenic potential of Stat3.Keywords
This publication has 24 references indexed in Scilit:
- Involvement of Human Micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell LinesGastroenterology, 2006
- BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcriptionOncogene, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- The role of IL-6 and STAT3 in inflammation and cancerEuropean Journal Of Cancer, 2005
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancerNature Clinical Practice Oncology, 2005
- Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAsRNA, 2004
- MicroRNAs Modulate Hematopoietic Lineage DifferentiationScience, 2004
- Interleukin-6–dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family–independent survival pathway closely associated with Stat3 activationBlood, 2004
- Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphomaBlood, 2003